| Code | 20586 | ||||||||||
| MA number | 21/0418/10-S | ||||||||||
| Product Form: | tbl plg 50x500 mg (fľ.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.06.2010 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Convulex CR 500 mg_04.2022.pdf
|
| SPC: |
SPC_Convulex CR 500 mg_04.2022.pdf
|
| Dokument: |
DHPC_Valproát_19.02.2024.pdf
|
| Safety feature | Yes |
| Data update: | 18.12.2018 |
